Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trialMANNS, Michael; MARCELLIN, Patrick; LENZ, Oliver et al.Lancet (British edition). 2014, Vol 384, Num 9941, pp 414-426, issn 0140-6736, 13 p.Article

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trialJACOBSON, Ira M; DORE, Gregory J; OUWERKERK-MAHADEVAN, Sivi et al.Lancet (British edition). 2014, Vol 384, Num 9941, pp 403-413, issn 0140-6736, 11 p.Article